530 related articles for article (PubMed ID: 9223407)
1. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
Dunn CS; Hurtrel B; Beyer C; Gloeckler L; Ledger TN; Moog C; Kieny MP; Mehtali M; Schmitt D; Gut JP; Kirn A; Aubertin AM
AIDS Res Hum Retroviruses; 1997 Jul; 13(11):913-22. PubMed ID: 9223407
[TBL] [Abstract][Full Text] [Related]
2. High viral load and CD4 lymphopenia in rhesus and cynomolgus macaques infected by a chimeric primate lentivirus constructed using the env, rev, tat, and vpu genes from HIV-1 Lai.
Dunn CS; Beyer C; Kieny MP; Gloeckler L; Schmitt D; Gut JP; Kirn A; Aubertin AM
Virology; 1996 Sep; 223(2):351-61. PubMed ID: 8806570
[TBL] [Abstract][Full Text] [Related]
3. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
Voss G; Li J; Manson K; Wyand M; Sodroski J; Letvin NL
Virology; 1995 Apr; 208(2):770-5. PubMed ID: 7747449
[TBL] [Abstract][Full Text] [Related]
5. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.
Miller CJ; McChesney MB; Lü X; Dailey PJ; Chutkowski C; Lu D; Brosio P; Roberts B; Lu Y
J Virol; 1997 Mar; 71(3):1911-21. PubMed ID: 9032322
[TBL] [Abstract][Full Text] [Related]
6. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
[TBL] [Abstract][Full Text] [Related]
7. Infectivity and immunogenicity of SIVmac/HIV-1 chimeric viruses (SHIVs) with deletions in two or three genes (vpr, nef and vpx).
Igarashi T; Kuwata T; Yamamoto H; Moriyama H; Ui M; Miyazaki Y; Hayami M
Microbiol Immunol; 1998; 42(1):71-4. PubMed ID: 9525784
[TBL] [Abstract][Full Text] [Related]
8. Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys.
Igarashi T; Shibata R; Hasebe F; Ami Y; Shinohara K; Komatsu T; Stahl-Hennig C; Petry H; Hunsmann G; Kuwata T
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):1021-9. PubMed ID: 7811533
[TBL] [Abstract][Full Text] [Related]
9. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope.
Quesada-Rolander M; Mäkitalo B; Thorstensson R; Zhang YJ; Castaños-Velez E; Biberfeld G; Putkonen P
AIDS Res Hum Retroviruses; 1996 Jul; 12(11):993-9. PubMed ID: 8827215
[TBL] [Abstract][Full Text] [Related]
10. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
11. Genomic and biological alteration of a human immunodeficiency virus type 1 (HIV-1)-simian immunodeficiency virus strain mac chimera, with HIV-1 Env, recovered from a long-term carrier monkey.
Igarashi T; Kuwata T; Takehisa J; Ibuki K; Shibata R; Mukai R; Komatsu T; Adachi A; Ido E; Hayami M
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1649-58. PubMed ID: 8760411
[TBL] [Abstract][Full Text] [Related]
12. An HIV-1 infection-related idiotype/clonotype (1F7) is expressed on antibodies directed to envelope glycoprotein in simian immunodeficiency virus- and chimeric simian/human immunodeficiency virus-infected rhesus monkeys.
Müller S; Margolin DH; Min G
Hybridoma; 1997 Feb; 16(1):17-21. PubMed ID: 9085123
[TBL] [Abstract][Full Text] [Related]
13. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
[TBL] [Abstract][Full Text] [Related]
14. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).
Luciw PA; Pratt-Lowe E; Shaw KE; Levy JA; Cheng-Mayer C
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7490-4. PubMed ID: 7638218
[TBL] [Abstract][Full Text] [Related]
15. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
16. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus.
Stott EJ; Almond N; Kent K; Walker B; Hull R; Rose J; Silvera P; Sangster R; Corcoran T; Lines J; Silvera K; Luciw P; Murphy-Corb M; Momin P; Bruck C
J Gen Virol; 1998 Mar; 79 ( Pt 3)():423-32. PubMed ID: 9519819
[TBL] [Abstract][Full Text] [Related]
18. Gene-mutated HIV-1/SIV chimeric viruses as AIDS live attenuated vaccines for potential human use.
Hayami M; Igarashi T; Kuwata T; Ui M; Haga T; Ami Y; Shinohara K; Honda M
Leukemia; 1999 Apr; 13 Suppl 1():S42-7. PubMed ID: 10232364
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L
J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
